Sexual asthenia | Treatment No. : | CD0278 | | Dosage & Instructions: | Chewing two tablets twice a day before meal.
| | Composition: | Selenium met D3 Aurum muriaticum D4 Chininum sulf D4 Ferrum phos D3 Natrum carb D3 Ginseng D4 Kola D3 Conium maculatum D4 Damiana D4 | | Contra-Indications: | None established | | Storage: | Store in a cool and dry place | | Precautions: | Keep away from the reach of children | | Standard Packaging : | 80 Tabs | | Order Online: | One 80 tabs bottle for $79.99 Two 80 tabs bottles for $129.99 | Condition Overview: The primary care physician frequently encounters patients complaining of fatigue, which has been estimated to afflict 10% of adult male patients in an urban setting. The physical, psychosomatic or purely emotional manifestations of this problem tend to follow patterns set by the constitution and personality of the individual patient. Sexual dysfunction is becoming more and more prominent among these symptoms of fatigue. It is associated with social and cultural risk factors, as well as with age. After the age of 40, 50% of patients giving a history of a deficiency state of the asthenic type focus their clinical history on the areas of erection and libido. It is frequently noted that the therapeutic response to the commonly used treatments for these conditions is not satisfactory. The use of a botanical product, whose active principal is currently used in a French overseas territory for these functional asthenias of a sexual type, is an alternative that at least offers an assurance of harmlessness and tolerance in subjects otherwise in good health. The primary care physician frequently encounters patients complaining of fatigue, which has been estimated to afflict 10% of adult male patients in an urban setting. The physical, psychosomatic or purely emotional manifestations of this problem tend to follow patterns set by the constitution and personality of the individual patient. Sexual dysfunction is becoming more and more prominent among these symptoms of fatigue. It is associated with social and cultural risk factors, as well as with age. After the age of 40, 50% of patients giving a history of a deficiency state of the asthenic type focus their clinical history on the areas of erection and libido. It is frequently noted that the therapeutic response to the commonly used treatments for these conditions is not satisfactory. The use of a botanical product, whose active principal is currently used in a French overseas territory for these functional asthenias of a sexual type, is an alternative that at least offers an assurance of harmlessness and tolerance in subjects otherwise in good health. |